Canada Says Reference Price Changes Could Save Payers Billions
Changes to Canada’s reference pricing system kick in on 1 July and could save billions.
You may also be interested in...
Provisional guidance on controversial pricing reforms is now in place in Canada.
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
The Scottish health technology appraisal body, the SMC, has announced its recommendations on Sanofi’s Dupixent, Ipsen’s Cabometyx, Sobi’s Zynlonta and Novartis’ Cosentyx.